Status:
COMPLETED
PDL1 in Ovarian High Grade Serous Carcinoma
Lead Sponsor:
Port Said University hospital
Collaborating Sponsors:
Mansoura University Hospital
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
50-70 years
Brief Summary
the main purpose is to study the prognostic effect of PDL1 in ovarian cancer especially HGSC. Therefore, in the present study the investigators analyzed the expression of PDL1in HGSC by immunohistoche...
Detailed Description
this cross-sectional study on 54 specimens of primary ovarian high grade serous carcinoma cases who attended to Oncology Centre, Mansoura University, Mansoura, Egypt in the period from 2012 till 2019....
Eligibility Criteria
Inclusion
- patients diagnosed with primary ovarian cancer
Exclusion
- patients with metastatic ovarian cancer
Key Trial Info
Start Date :
December 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT04507191
Start Date
December 1 2012
End Date
December 30 2019
Last Update
August 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Port Said University
Port Said, Egypt, 42511